Cargando…
No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576594/ https://www.ncbi.nlm.nih.gov/pubmed/34772647 http://dx.doi.org/10.1016/j.acvd.2021.10.003 |
| _version_ | 1784595909189828608 |
|---|---|
| author | Ferreira, João Pedro Girerd, Nicolas Rocca, Hans-Peter Brunner-La Pellicori, Pierpaolo Cleland, John G. Rossignol, Patrick Zannad, Faiez |
| author_facet | Ferreira, João Pedro Girerd, Nicolas Rocca, Hans-Peter Brunner-La Pellicori, Pierpaolo Cleland, John G. Rossignol, Patrick Zannad, Faiez |
| author_sort | Ferreira, João Pedro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8576594 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85765942021-11-09 No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial Ferreira, João Pedro Girerd, Nicolas Rocca, Hans-Peter Brunner-La Pellicori, Pierpaolo Cleland, John G. Rossignol, Patrick Zannad, Faiez Arch Cardiovasc Dis Research Letter Elsevier Masson SAS. 2021-12 2021-11-09 /pmc/articles/PMC8576594/ /pubmed/34772647 http://dx.doi.org/10.1016/j.acvd.2021.10.003 Text en © 2021 Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Research Letter Ferreira, João Pedro Girerd, Nicolas Rocca, Hans-Peter Brunner-La Pellicori, Pierpaolo Cleland, John G. Rossignol, Patrick Zannad, Faiez No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial |
| title | No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial |
| title_full | No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial |
| title_fullStr | No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial |
| title_full_unstemmed | No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial |
| title_short | No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial |
| title_sort | no influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: findings from the homage randomized trial |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576594/ https://www.ncbi.nlm.nih.gov/pubmed/34772647 http://dx.doi.org/10.1016/j.acvd.2021.10.003 |
| work_keys_str_mv | AT ferreirajoaopedro noinfluenceofspironolactoneonplasmaconcentrationsofangiotensinconvertingenzyme2findingsfromthehomagerandomizedtrial AT girerdnicolas noinfluenceofspironolactoneonplasmaconcentrationsofangiotensinconvertingenzyme2findingsfromthehomagerandomizedtrial AT roccahanspeterbrunnerla noinfluenceofspironolactoneonplasmaconcentrationsofangiotensinconvertingenzyme2findingsfromthehomagerandomizedtrial AT pellicoripierpaolo noinfluenceofspironolactoneonplasmaconcentrationsofangiotensinconvertingenzyme2findingsfromthehomagerandomizedtrial AT clelandjohng noinfluenceofspironolactoneonplasmaconcentrationsofangiotensinconvertingenzyme2findingsfromthehomagerandomizedtrial AT rossignolpatrick noinfluenceofspironolactoneonplasmaconcentrationsofangiotensinconvertingenzyme2findingsfromthehomagerandomizedtrial AT zannadfaiez noinfluenceofspironolactoneonplasmaconcentrationsofangiotensinconvertingenzyme2findingsfromthehomagerandomizedtrial |